Physician profile
Jamie Louise Barkmeyer
NPI 1689042087
$3,831.14
in general payments reported to CMS, 2019-2025
23 companies · $1,370 in 2025
The $1,370 reported for 2025 was more than what 98% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $227 · 2022: $1,136 · 2023: $725 · 2024: $374 · 2025: $1,370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,468.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $900.45 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $877.51 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $388.76 | 2023-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $237.16 | 2021-2025 | Slynd, Twirla |
| Myovant Sciences INC. | $208.69 | 2021-2022 | |
| Sage Therapeutics, LLC | $172.76 | 2024-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $171.77 | 2022-2025 | Injectafer |
| Coopersurgical, INC. | $119.32 | 2021-2025 | Paragard T 380a, Paragard T 380a |
| Astellas Pharma US INC | $112.70 | 2025 | Veozah |
| Shield Therapeutics INC | $106.62 | 2024-2025 | |
| Pfizer INC. | $93.00 | 2022-2023 | |
| Evofem Biosciences, INC. | $88.83 | 2023-2025 | Phexxi, Solosec, Phexx |
| Mylan Pharmaceuticals INC. | $61.79 | 2021-2022 | |
| Organon LLC | $39.89 | 2022-2023 | Nexplanon |
| Axonics, INC. | $36.53 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $34.39 | 2022 | |
| Boston Scientific Corporation | $33.85 | 2023 | Wavewriter Alpha Prime 16 |
| Agile Therapeutics, INC. | $29.38 | 2021-2022 | |
| Avion Pharmaceuticals | $27.93 | 2021-2022 | |
| Hologic Sales and Service, LLC | $27.26 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Urovant Sciences INC | $22.96 | 2022 | |
| Smith+Nephew, INC. | $21.01 | 2024 | Pico |
| Amgen INC. | $18.58 | 2024 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Barkmeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.